home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Long-Lasting Craving For Cocaine

  March, 30 2004 9:36
your information resource in human molecular genetics
Recovered drug addicts often continue to crave the drug for many years, and such cravings are linked to the long-term risk of relapse. These 'automatic' responses to drug use may develop more quickly than previously thought, suggests a paper in the May issue of Nature Neuroscience. Learning in response to a single cocaine exposure was more persistent than learning in response to a more conventional reward, a tasty food.

Roberto Ciccocioppo and colleagues trained rats to press a lever for food, then one day surprised the animals by delivering intravenous cocaine instead of food when they pressed the lever. This unusual condition was signaled by a loud noise that occurred when cocaine became available, and the rats learned to press the lever more vigorously when the noise occurred because they associated it with the drug. After a single exposure to cocaine, the rats continued to respond to the noise by increasing their lever pressing for nearly a year. In contrast, when the unexpected reward of sweetened condensed milk was signaled by a similar procedure in a different group of rats, it took less than three months for the animals to stop responding to the signal that indicated its availability. The authors conclude that learned responses to drug-related environmental stimuli may be important not only in relapse risk, but also in the motivation to repeat an initial drug experience.

Author contact:

Roberto Ciccocioppo
University of Camerino, Italy
Tel: +39 0737 403313
E-mail: roberto.ciccocioppo@unicam.it

Also available online.

(C) Nature Neuroscience press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.